lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet

RxCUI: 672149
RxNorm name: lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet
Display name: lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet
Full name: lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TYKERB	LAPATINIB	Novartis Pharmaceuticals Corporation	eee37f88-ec6a-4c30-b8aa-e2c71f93088c	2026-01-27	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 672149
Lapatinib	LAPATINIB	Lupin Pharmaceuticals, Inc.	50d0dd0c-7682-43d0-aa1b-ca26e9181aee	2025-06-10	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 672149
Lapatinib	LAPATINIB	AvKARE	302a4346-a68d-af3e-e063-6294a90a4a6f	2025-03-12	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 672149
Lapatinib	LAPATINIB	Teva Pharmaceuticals, Inc.	b09abf73-1eef-4e12-b400-c030d546d223	2023-11-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 672149

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
eee37f88-ec6a-4c30-b8aa-e2c71f93088c	lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet	SY	14	These highlights do not include all the information needed to use TYKERB safely and effectively. See full prescribing information for TYKERB. TYKERB ® (lapatinib) tablets, for oral use Initial U.S. Approval: 2007	20260127
eee37f88-ec6a-4c30-b8aa-e2c71f93088c	lapatinib 250 MG Oral Tablet	PSN	14	These highlights do not include all the information needed to use TYKERB safely and effectively. See full prescribing information for TYKERB. TYKERB ® (lapatinib) tablets, for oral use Initial U.S. Approval: 2007	20260127
eee37f88-ec6a-4c30-b8aa-e2c71f93088c	lapatinib 250 MG Oral Tablet	SCD	14	These highlights do not include all the information needed to use TYKERB safely and effectively. See full prescribing information for TYKERB. TYKERB ® (lapatinib) tablets, for oral use Initial U.S. Approval: 2007	20260127
b09abf73-1eef-4e12-b400-c030d546d223	lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet	SY	7	These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. LAPATINIB tablets, for oral use Initial U.S. Approval: 2007	20231130
b09abf73-1eef-4e12-b400-c030d546d223	lapatinib 250 MG Oral Tablet	PSN	7	These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. LAPATINIB tablets, for oral use Initial U.S. Approval: 2007	20231130
b09abf73-1eef-4e12-b400-c030d546d223	lapatinib 250 MG Oral Tablet	SCD	7	These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. LAPATINIB tablets, for oral use Initial U.S. Approval: 2007	20231130
50d0dd0c-7682-43d0-aa1b-ca26e9181aee	lapatinib 250 MG Oral Tablet	SCD	4	These highlights do not include all the information needed to use lapatinib tablets safely and effectively. See full prescribing information for lapatinib tablets. LAPATINIB tablets, for oral use Initial U.S. Approval: 2007	20250610
50d0dd0c-7682-43d0-aa1b-ca26e9181aee	lapatinib 250 MG Oral Tablet	PSN	4	These highlights do not include all the information needed to use lapatinib tablets safely and effectively. See full prescribing information for lapatinib tablets. LAPATINIB tablets, for oral use Initial U.S. Approval: 2007	20250610
50d0dd0c-7682-43d0-aa1b-ca26e9181aee	lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet	SY	4	These highlights do not include all the information needed to use lapatinib tablets safely and effectively. See full prescribing information for lapatinib tablets. LAPATINIB tablets, for oral use Initial U.S. Approval: 2007	20250610
302a4346-a68d-af3e-e063-6294a90a4a6f	lapatinib 250 MG Oral Tablet	PSN	1	LAPATINIB tablets, for oral use These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. Initial U.S. Approval: 2007	20250312
302a4346-a68d-af3e-e063-6294a90a4a6f	lapatinib 250 MG Oral Tablet	SCD	1	LAPATINIB tablets, for oral use These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. Initial U.S. Approval: 2007	20250312
302a4346-a68d-af3e-e063-6294a90a4a6f	lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet	SY	1	LAPATINIB tablets, for oral use These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. Initial U.S. Approval: 2007	20250312